rs10456

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006383.4(CIB2):​c.477C>T​(p.Asp159Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.228 in 1,614,016 control chromosomes in the GnomAD database, including 44,678 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3096 hom., cov: 32)
Exomes 𝑓: 0.23 ( 41582 hom. )

Consequence

CIB2
NM_006383.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.392

Publications

23 publications found
Variant links:
Genes affected
CIB2 (HGNC:24579): (calcium and integrin binding family member 2) The protein encoded by this gene is similar to that of KIP/CIB, calcineurin B, and calmodulin. The encoded protein is a calcium-binding regulatory protein that interacts with DNA-dependent protein kinase catalytic subunits (DNA-PKcs), and it is involved in photoreceptor cell maintenance. Mutations in this gene cause deafness, autosomal recessive, 48 (DFNB48), and also Usher syndrome 1J (USH1J). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
CIB2 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Usher syndrome type 1J
    Inheritance: Unknown, AR Classification: DEFINITIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive nonsyndromic hearing loss 48
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 1
    Inheritance: AR Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 15-78105804-G-A is Benign according to our data. Variant chr15-78105804-G-A is described in ClinVar as Benign. ClinVar VariationId is 226517.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.392 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.244 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CIB2NM_006383.4 linkc.477C>T p.Asp159Asp synonymous_variant Exon 5 of 6 ENST00000258930.8 NP_006374.1 O75838-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CIB2ENST00000258930.8 linkc.477C>T p.Asp159Asp synonymous_variant Exon 5 of 6 1 NM_006383.4 ENSP00000258930.3 O75838-1

Frequencies

GnomAD3 genomes
AF:
0.186
AC:
28251
AN:
152058
Hom.:
3099
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0778
Gnomad AMI
AF:
0.170
Gnomad AMR
AF:
0.165
Gnomad ASJ
AF:
0.292
Gnomad EAS
AF:
0.0224
Gnomad SAS
AF:
0.153
Gnomad FIN
AF:
0.303
Gnomad MID
AF:
0.206
Gnomad NFE
AF:
0.247
Gnomad OTH
AF:
0.196
GnomAD2 exomes
AF:
0.204
AC:
51300
AN:
251430
AF XY:
0.207
show subpopulations
Gnomad AFR exome
AF:
0.0731
Gnomad AMR exome
AF:
0.164
Gnomad ASJ exome
AF:
0.284
Gnomad EAS exome
AF:
0.0177
Gnomad FIN exome
AF:
0.307
Gnomad NFE exome
AF:
0.248
Gnomad OTH exome
AF:
0.230
GnomAD4 exome
AF:
0.233
AC:
339996
AN:
1461840
Hom.:
41582
Cov.:
35
AF XY:
0.231
AC XY:
168166
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.0728
AC:
2437
AN:
33480
American (AMR)
AF:
0.166
AC:
7434
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.287
AC:
7504
AN:
26136
East Asian (EAS)
AF:
0.0224
AC:
888
AN:
39700
South Asian (SAS)
AF:
0.162
AC:
14000
AN:
86256
European-Finnish (FIN)
AF:
0.306
AC:
16317
AN:
53410
Middle Eastern (MID)
AF:
0.221
AC:
1277
AN:
5768
European-Non Finnish (NFE)
AF:
0.249
AC:
276624
AN:
1111974
Other (OTH)
AF:
0.224
AC:
13515
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
17334
34668
52003
69337
86671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9108
18216
27324
36432
45540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.186
AC:
28240
AN:
152176
Hom.:
3096
Cov.:
32
AF XY:
0.187
AC XY:
13880
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0776
AC:
3221
AN:
41528
American (AMR)
AF:
0.165
AC:
2521
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
1014
AN:
3470
East Asian (EAS)
AF:
0.0228
AC:
118
AN:
5176
South Asian (SAS)
AF:
0.152
AC:
733
AN:
4826
European-Finnish (FIN)
AF:
0.303
AC:
3205
AN:
10586
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.247
AC:
16803
AN:
67976
Other (OTH)
AF:
0.193
AC:
408
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1183
2365
3548
4730
5913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.223
Hom.:
11843
Bravo
AF:
0.171
Asia WGS
AF:
0.0960
AC:
334
AN:
3478
EpiCase
AF:
0.253
EpiControl
AF:
0.245

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 01, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Asp159Asp in exon 5 of CIB2: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 24.4% (2095/8586) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs10456). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.26
DANN
Benign
0.80
PhyloP100
-0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10456; hg19: chr15-78398146; COSMIC: COSV51948497; COSMIC: COSV51948497; API